Drug intelligence / Profile preview

Amlycure D.S.

Development stage
Unknown
Lead developer
Aimil
Administration
Oral
01

Overview

Amlycure D.S. is a high-strength Ayurvedic polyherbal formulation developed by Aimil Pharmaceuticals for the management of various liver disorders and the promotion of hepatic health. Available in capsule and syrup forms, the capsule variant contains a concentrated blend of herbal extracts including *Picrorhiza kurroa* (Kutaki), *Andrographis paniculata* (Kalmegh), *Boerhavia diffusa* (Punernava), and *Phyllanthus niruri* (Bhuiamla). The formulation is designed to act as a hepatoprotective and hepatostimulative agent, working at the cellular level to maintain hepatocyte integrity, normalize liver enzymes (LFT parameters), and support detoxification. It is clinically indicated for conditions such as fatty liver (steatosis), alcohol-induced liver damage, drug-induced hepatotoxicity, and digestive complaints like indigestion and loss of appetite.

Brand names
Amlycure D.S.
Other names
Amlycure D.S. Capsules

Beyond the preview

Go deeper on Amlycure D.S..

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amlycure D.S..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call